✨ Medicines Act Notices




3390
NEW ZEALAND GAZETTE
No. 142

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Rapilysin.

Active Ingredient(s): Reteplase 10U.

Dosage Form: Powder for injection.

NZ Sponsor: Roche Products (New Zealand) Limited.

Manufacturer(s): Roche Diagnostics GmbH, Mannheim, Germany.

Dated this 30th day of September 1999.

S. S. JESSAMINE, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go7287

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Full Marks.

Active Ingredient(s): Phenothrin 0.5% w/w.

Dosage Form: Topical emulsion.

NZ Sponsor: Pharmaco (NZ) Limited.

Manufacturer(s): Simco Limited, Vale, Guernsey, Channel Islands.

Product: Lanate Skin Cream.

Active Ingredient(s): Ammonium lactate 17.5 mg/mL.

Dosage Form: Topical cream.

NZ Sponsor: Douglas Pharmaceuticals Limited.

Manufacturer(s): Douglas Pharmaceuticals Limited, Manufacturing Division, Henderson, Auckland.

Product: Timohexal.

Active Ingredient(s): Timolol maleate 3.42 mg/mL equivalent to 2.5 mg/mL timohexal.

Dosage Form: Eye drops, solution.

NZ Sponsor: Hexal New Zealand Limited.

Manufacturer(s): Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany.

Product: Timohexal.

Active Ingredient(s): Timolol maleate 6.83 mg/mL equivalent to 5 mg/mL timohexal.

Dosage Form: Eye drops, solution.

NZ Sponsor: Hexal New Zealand Limited.

Manufacturer(s): Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany.

Dated this 30th day of September 1999.

S. S. JESSAMINE, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go7284



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1999, No 142


NZLII PDF NZ Gazette 1999, No 142





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of Changed Medicine

πŸ₯ Health & Social Welfare
30 September 1999
Medicines Act, Changed Medicine, Rapilysin, Reteplase, Roche Products, Injection
  • S. S. Jessamine, Acting Chief Advisor, Safety and Regulation

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
30 September 1999
Medicines Act, New Medicine, Full Marks, Phenothrin, Lanate Skin Cream, Ammonium Lactate, Timohexal, Timolol Maleate, Eye Drops
  • S. S. Jessamine, Acting Chief Advisor, Safety and Regulation